Skip to main content
. 2021 Sep 14;150(1):124–131. doi: 10.1002/ijc.33785

FIGURE 4.

FIGURE 4

Treatment choices in all patients diagnosed with HR+/HER2− ABC from 2009 until 2018 per calendar year in first, second and third line of therapy. Treatment choices are shown from 2010 in second‐line and from 2011 in third‐line to present a representative distribution of patients in next‐line treatment. ABC, advanced breast cancer; HER2, human epidermal growth factor receptor 2; HR, hormone receptor [Color figure can be viewed at wileyonlinelibrary.com]